Loxo Oncology, Inc. (LOXO) News Headlines

▮ More

Date

Headline

2/1/2019 7:00:44 AM Eli Lilly, Loxo Oncology Report Expiration Of HSR Act Waiting Period

2/1/2019 6:45:50 AM Lilly And Loxo Oncology Report Expiration Of HSR Act Waiting Period

1/8/2019 1:46:43 AM So Long, Loxo

1/7/2019 8:39:07 PM AXSM Awes Investors, LOXO Snapped Up For $8 Bln, SAGE Excited, TLC On Watch

1/7/2019 2:49:10 PM Loxo Oncology Holding On To Substantial Gain In Afternoon Trading

1/7/2019 9:44:42 AM Loxo Oncology Inc. (LOXO) Has Broken Out To A New High After Bought By Lilly

1/7/2019 6:52:33 AM Lilly To Buy Loxo Oncology In $8.0 Bln Deal

1/7/2019 6:32:03 AM Eli Lilly To Acquire Loxo Oncology For $235/Shr Cash, Or $8.0 Bln

1/7/2019 6:31:34 AM Eli Lilly To Buy Loxo Oncology For $235/shr In Cash Or About $8.0 Bln

12/21/2018 6:47:35 AM Loxo Oncology Initiates Phase 1/2 Trial For Highly Selective, Non-Covalent BTK Inhibitor, LOXO-305

11/26/2018 8:58:50 PM FDA Okays Loxo Oncology - Bayer Cancer Drug

11/26/2018 7:45:30 PM Loxo : FDA Oks Vitrakvi, First Ever TRK Inhibitor, For Patients With Advanced Solid Tumors Harboring NTRK Gene Fusion

11/8/2018 6:54:08 AM Loxo Oncology Q3 Loss Per Share $0.89 Vs Loss $2.45 Last Year

10/29/2018 2:55:33 AM Biotech Stocks Facing FDA Decision In November

10/21/2018 10:12:18 AM Loxo Oncology Announces Larotrectinib Update In Patients With TRK Fusion Cancers

10/15/2018 6:50:46 AM Loxo Oncology Announces Receipt Of Breakthrough Therapy Designation From FDA For LOXO-292

10/9/2018 6:52:16 AM Loxo Oncology Announces Details For Data Presentations At The European Society For Medical Oncology 2018 Congress

10/6/2018 9:22:21 AM Loxo Oncology Announces Updated Interim Clinical Data For LOXO-292 From Global Phase 1/2 LIBRETTO-001 Trial

9/22/2018 4:07:24 AM Week Ahead In Pharmaceuticals: 10 Stocks To Watch (CKPT, SNDX, ADMP...)

9/5/2018 6:47:59 AM Loxo Oncology Announces Receipt Of Breakthrough Therapy Designation From FDA For LOXO-292